# Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program

> **NCT02933346** · — · COMPLETED · sponsor: **Intergroupe Francophone de Cancerologie Thoracique** · enrollment: 907 (actual)

## Conditions studied

- Non-small Cell Lung Cancer
- Nivolumab
- Long-term Adverse Effects

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02933346
- **Lead sponsor:** Intergroupe Francophone de Cancerologie Thoracique
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2016-09
- **Primary completion:** 2018-01
- **Final completion:** 2020-12-15
- **Target enrollment:** 907 (ACTUAL)
- **Last updated:** 2023-05-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02933346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02933346, "Cohort of Patients With NSCLC Treated With Nivolumab Under the ATU Program". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02933346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*